MarketScreener Homepage > Equities > Nasdaq > Henry Schein, Inc. HSIC

Report

Delayed Nasdaq - 11/25 04:00:00 pm
64.13	USD		-0.68%

08:05a

HENRY SCHEIN : Announces Virtual Presence at Greater New York Dental Meeting Focused on 3D Imaging, 3D Printing, and CAD/CAM Solutions

11/17

HENRY SCHEIN : Announces Participation in Upcoming Virtual Conferences in December

11/02

HENRY SCHEIN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

11/19/2020	11/20/2020	11/23/2020	11/24/2020	11/25/2020	Date
63.5(c)	63.58(c)	63.71(c)	64.57(c)	64.13(c)	Last
935 492	665 907	874 935	510 476	568 718	Volume
-1.15%	+0.13%	+0.20%	+1.35%	-0.68%	Change

More quotes

Financials (USD)

Sales 2020	9 823 M - -
Net income 2020	401 M - -
Net Debt 2020	412 M - -
P/E ratio 2020	22,7x
Yield 2020	-

Sales 2021	10 919 M - -
Net income 2021	522 M - -
Net Debt 2021	180 M - -
P/E ratio 2021	17,6x
Yield 2021	-

Capitalization	9 219 M 9 219 M -
EV / Sales 2020	0,98x
EV / Sales 2021	0,86x
Nbr of Employees	19 000
Free-Float	98,6%

More Financials

Company

Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows: - distribution of health care products and equipments (94.8%): dental products and equipments (67.7% of sales; consumable products, laboratory equipment, print materials, implants,...

Sector

Medical Equipment, Supplies & Distribution

Calendar

12/01 | 01:00pm

Presentation

More about the company

Notations Surperformance© of Henry Schein, Inc.

Trading Rating :

Investor Rating :

More Ratings

All news about HENRY SCHEIN, INC.

08:05a	HENRY SCHEIN : Announces Virtual Presence at Greater New York Dental Meeting Foc..	BU
11/17	HENRY SCHEIN : Announces Participation in Upcoming Virtual Conferences in Decemb..	BU
11/02	HENRY SCHEIN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..	AQ
11/02	HENRY SCHEIN : Vertical Market Data	PU
11/02	HENRY SCHEIN : Reconciliation of GAAP and Non-GAAP Measures	PU
11/02	HENRY SCHEIN : 3Q Earnings Snapshot	AQ
10/28	HENRY SCHEIN, INC. : quaterly earnings release
10/28	HENRY SCHEIN : Announces Distribution Agreement with Carrizo Dental to Provide O..	BU
10/27	HENRY SCHEIN : Announces Participation in Upcoming Virtual Conferences in Novemb..	BU
10/26	HENRY SCHEIN : TDSC.com, Powered by Henry Schein Is Now Live	BU
10/21	HENRY SCHEIN : Supports the Global Fight Against Cancer Through Its Practice Pin..	BU
10/20	HENRY SCHEIN CARES FOUNDATION : Launches the ‘Wearing Is Caring' Campaign ..	BU
10/19	HENRY SCHEIN TO WEBCAST THIRD QUARTE : 00 a.m. et	BU
10/09	HENRY SCHEIN : Opens Customer Assistance Hotline in Response to Hurricane Delta	BU
09/21	HENRY SCHEIN : Named to Fortune® Magazine's ‘Change the World' List	BU

More news

News in other languages on HENRY SCHEIN, INC.

10/28	HENRY SCHEIN, INC. : Veröffentlichung des Quartalsergebnisses
10/28	HENRY SCHEIN, INC. : publication des résultats trimestriels
2019	USA/OPIOÏDES : J&J va verser 20 million de dollars pour éviter un procès fédéral
2019	HENRY SCHEIN : und Vets First Choice geben Vorstand für Covetrus bekannt
2018	HENRY SCHEIN UND VETS FIRST CHOICE G : Covetrus

More news

Analyst Recommendations on HENRY SCHEIN, INC.

2018	Legal hurdles, not Amazon, key concern for U.S. dental supply firms	RE
2014	Danaher to buy Nobel Biocare for $2.2 billion	RE
2014	Danaher to buy Nobel Biocare for $2.2 billion	RE

More recommendations

Provided by Scoopnest.com

Chart HENRY SCHEIN, INC.

Duration : Period :

Henry Schein, Inc. Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends HENRY SCHEIN, INC.

	Short Term	Mid-Term	Long Term
Trends	Neutral	Neutral	Neutral

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	HOLD
Number of Analysts	18
Average target price	70,20 $
Last Close Price	64,57 $
Spread / Highest target	39,4%
Spread / Average Target	8,72%
Spread / Lowest Target	-8,63%

Consensus

EPS Revisions

More Estimates Revisions

Managers

Name	Title
Stanley M. Bergman	Chairman & Chief Executive Officer
James P. Breslawski	Vice Chairman & President
Steven Paladino	Chief Financial Officer, Director & Executive VP
Christopher Pendergast	Chief Technology Officer & Senior Vice President
Philip A. Laskaway	Lead Independent Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

HENRY SCHEIN, INC.	-3.22%	9 219



AS ONE CORPORATION	54.26%	2 813
CANTEL MEDICAL CORP.	-16.35%	2 506
SHIP HEALTHCARE HOLDINGS, INC.	0.59%	2 290
OWENS & MINOR, INC.	385.69%	1 846
TOKAI CORP.	-28.08%	691

More Results